Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.46 |
| ▸ | AHR | P35869 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | FBP1 | P09467 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.39 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.39 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2080028 | 1.00 | ADRB2 (0.46) | ADRB2AHRSLC6A2SLC6A3CYP1A2 | |
| SCHEMBL2077774 | 1.00 | ADRB2 (0.46) | ADRB2AHRSLC6A2SLC6A3CYP1A2 | |
| SCHEMBL12784436 | 1.00 | ADRB2 (0.46) | ADRB2AHRSLC6A2SLC6A3CYP1A2 | |
| SCHEMBL2077776 | 1.00 | ADRB2 (0.46) | ADRB2AHRSLC6A2SLC6A3CYP1A2 | |
| SCHEMBL10131184 | 0.82 | AHR (0.48) | AHRCYP1A2ALOX5PTGS1PTGS2 | |
| SCHEMBL9967711 | 0.82 | AHR (0.48) | AHRCYP1A2ALOX5PTGS1PTGS2 | |
| SCHEMBL14465008 | 0.82 | AHR (0.48) | AHRCYP1A2ALOX5PTGS1PTGS2 | |
| SCHEMBL7373692 | 0.78 | NFE2L2 (0.50) | ALOX5PTGS1PTGS2FBP1NFE2L2 | |
| SCHEMBL8783722 | 0.78 | MAPT (0.52) | GRIK1GRIK2 | |
| SCHEMBL10365515 | 0.78 | AHR (0.45) | ADRB2AHRCYP1A2ALOX5PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018100191-A1 | AGROCHEMICAL COMPOSITIONS COMPRISING PHENYL-PROPANOIC ACID DERIVATIVES FOR CROP YIELD INCREASE | VIB VZW (BE) | 2018-06-07 | — | — | WO | disclosed |
| US-7897601-B2 | Cannabinoid receptor modulators | INTERVET, INC. (US) | 2011-03-01 | — | — | US | disclosed |
| US-7897601-B2 | Cannabinoid receptor modulators | INTERVET, INC. (US) | 2011-03-01 | — | — | US | disclosed |
| US-20070197628-A1 | Cannabinoid receptor modulators | INTERVET INTERNATIONAL B.V. (NL) | 2007-08-23 | — | — | US | disclosed |
| US-20070197628-A1 | Cannabinoid receptor modulators | INTERVET INTERNATIONAL B.V. (NL) | 2007-08-23 | — | — | US | disclosed |
| WO-2007084450-A2 | CANNIBINOID RECEPTOR MODULATORS | SCHERING CORPORATION (US) | 2007-07-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070197628-A1 | Cannabinoid receptor modulators | CNR1, CNR2, GPR18 | ADRB2 73/4885AHR 311/4885SLC6A2 518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.